周大生(002867.SZ):公司鑽石鑲嵌產品在行業中具備優勢,目前存量5100多家門店以及後續的新增門店可以消化庫存
格隆匯5月27日丨周大生(002867.SZ)在投資者互動平台表示,鑲嵌產品雖然近年來需求下滑,但仍有市場存在;公司鑽石鑲嵌產品在行業中具備優勢,目前存量5100多家門店以及後續的新增門店可以消化庫存;同時針對鑲嵌產品,公司將加大鑲嵌產品推廣和促銷,同時通過分析款式,將一部分老舊/長期滯銷款式庫存產品召回拆解改款,這個過程可能會有損失工費,對於待拆解的鑽石鑲嵌產品會按會計準則規定進行減值測試後預計可能的減值損失,這部分影響金額較小,其他常規鑲嵌存貨從減值測試情況看暫無減值跡象。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.